Trial Profile
An Evaluation of Simvastatin 20 mg Plus Omacor [omega-3 ethylester concentrate] 4 g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; Simvastatin
- Indications Dyslipidaemias; Hyperlipoproteinaemia type V
- Focus Therapeutic Use
- 15 Aug 2008 Primary endpoint 'Non high density lipoprotein cholesterol' has been met.
- 16 Jul 2007 New trial record.